Amino-PEG6-amido-bis-PEG5-N3 is a cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Structure of
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Amino-PEG6-amido-bis-PEG5-N3 is a multifunctional polymer utilized in bioconjugation, drug delivery, and various other biomedical applications. Here are some key applications of Amino-PEG6-amido-bis-PEG5-N3:
Bioconjugation: Amino-PEG6-amido-bis-PEG5-N3 serves as a versatile linker in the conjugation of biomolecules, such as proteins, antibodies, and nucleic acids. By connecting different functional units, it facilitates the creation of sophisticated bioconjugates for diagnostics or therapeutic purposes. The PEG (polyethylene glycol) spacers enhance solubility and reduce immunogenicity of the conjugates.
Drug Delivery: In drug delivery systems, Amino-PEG6-amido-bis-PEG5-N3 is used to improve the solubility, stability, and bioavailability of pharmaceutical agents. The polymer's PEG chains offer stealth properties, reducing the recognition by the immune system and extending the circulation time of drug-loaded nanoparticles. This results in more effective and targeted delivery of drugs to diseased tissues.
Surface Modification: Amino-PEG6-amido-bis-PEG5-N3 is employed in the modification of surfaces to improve biocompatibility and prevent non-specific binding. By coating medical devices, biosensors, or nanoparticles with this polymer, researchers can reduce protein adsorption and cell adhesion. This is crucial in improving the performance and longevity of biomedical implants and diagnostics.
Advanced Research Tools: In cutting-edge research, Amino-PEG6-amido-bis-PEG5-N3 is used in the design of multifunctional nanomaterials for various applications, including imaging and targeted therapy. The molecule's functional groups allow for the attachment of multiple agents, such as imaging probes and therapeutic drugs, on a single nanocarrier. This enables the development of theranostic platforms that can diagnose and treat diseases simultaneously.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00896 | Amino-PEG5-propionic acid | 1191078-74-6 | |
BADC-00897 | Amino-PEG9-propionic acid | 1191079-83-0 | |
BADC-00915 | Amino-PEG6-t-butyl ester | 1286281-32-0 | |
BADC-00917 | Amino-PEG10-alcohol | 129449-09-8 | |
BADC-00958 | Amino-PEG4-Val-Cit-PAB-MMAE | 1492056-71-9 | |
BADC-00962 | Amino-PEG11-alcohol | 15332-94-2 | |
BADC-01024 | Amino-PEG4-acetic acid | 195071-49-9 | |
BADC-01091 | Aminooxy-amido-PEG4-propargyl | 2253965-03-4 | |
BADC-01663 | Aminooxy-PEG2-BCN | 2253965-14-7 | |
BADC-01117 | Amino-PEG5-alcohol | 34188-11-9 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.